網(wǎng)站主頁 >> CAS數(shù)據(jù)庫列表 >> N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
|
|
- CAS號:
- 155488-25-8
- 英文名:
- N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
- 英文別名:
- YM-220;Sograzepide;Estradiol-3-O-sulfamate;1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea;N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea;Urea, N-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-
- 中文名:
- N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
- 中文別名:
- 內(nèi)塔澤皮德;化合物 T16906;化合物 SOGRAZEPIDE;N-[(3R)-1-(3,3-二甲基-2-氧代丁基)-2,3-二氫-2-氧代-5-(2-吡啶基)-1H-1,4-苯并二氮雜卓-3-基]-N'-[3-(甲基氨基)苯基]脲
- CBNumber:
- CB92484809
- 分子式:
- C28H30N6O3
- 分子量:
- 498.58
- MOL File:
- 155488-25-8.mol
|
|
|
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea化學(xué)性質(zhì)
-
沸點(diǎn):
-
723.0±60.0 °C(Predicted)
-
|
-
密度:
-
1.25
-
|
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : ≥ 100 mg/mL (200.57 mM)
-
|
-
酸度系數(shù)(pKa):
-
11.38±0.40(Predicted)
-
|
-
形態(tài):
-
Solid
-
|
-
顏色:
-
Off-white to light yellow
-
|
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea性質(zhì)、用途與生產(chǎn)工藝
Sograzepide?(Netazepide; YF 476; YM-220) 是一種非常有效,高選擇性和口服活性的 Gastrin/CCK-B 拮抗劑,IC50 值為 0.1 nM,還抑制 Gastrin/CCK-A 活性, IC50 值
為 502 nM。Sograzepide?(Netazepide; YF 476; YM-220) 取代 [125I]CCK-8 與大鼠腦,克隆犬和人 Gastrin/CCK-B 的特異性結(jié)合,Ki 值分別為 0.068、0.62 和 0.19 nM。
IC50: 0.1 nM (Gastrin/CCK-B); 501 nM (Gastrin/CCK-A)
Sograzepide?(Netazepide; YF 476; YM-220) (0.1 μmol/kg; intravenous injection) has an inhibition effect on pentagastrin-induced gastric acid secretion in anethsetized rats with an ED
50
of 87?nmol/kg.
Sograzepide?(Netazepide; YF 476; YM-220) (intravenous injection; 10 μM/kg) inhibits pentagastrin-induced acid secretion with an ED
50
value of 0.0086 μM/kg, but does not affect histamine- and bethanechol-induced acid secretion.Sograzepide (Netazepide; YF 476; YM-220) (intravenous injection; oral administration) in Heidenhain pouch dogs, inhibits pentagastrin-stimulated gastric acid secretion in a dose-dependent manner with ED
50
values of 0.018 and 0.020 μM/kg, respectively .
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
上下游產(chǎn)品信息
上游原料
下游產(chǎn)品
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS編號 | 包裝 | 價格 |
---|
2025/02/08 | HY-14850 | Sograzepide | 155488-25-8 | 1 mg | 1136元 |
2025/02/08 | HY-14850 | N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea Sograzepide | 155488-25-8 | 5mg | 2500元 |
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
生產(chǎn)廠家
155488-25-8, N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea 相關(guān)搜索:
- 抑制劑
- C28H30N6O3
- 化合物 SOGRAZEPIDE
- 化合物 T16906
- 內(nèi)塔澤皮德
- N-[(3R)-1-(3,3-二甲基-2-氧代丁基)-2,3-二氫-2-氧代-5-(2-吡啶基)-1H-1,4-苯并二氮雜卓-3-基]-N'-[3-(甲基氨基)苯基]脲
- 155488-25-8
- YM-220
- Urea, N-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-
- 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
- Estradiol-3-O-sulfamate
- Sograzepide
- N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea